Clinical trial
PAC-MAN (LDL-like nanoparticle paclitaxel)
NCT04148833
Tolerated, no significant between-group CTA plaque benefit in a small pilot.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT04148833
Original sources
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.